Navigation Links
Hospitals Make Positive Strides to Reduce Wait Times for Patients

The waiting times for patients in Canada’s hospitals has improved, but targets for some emergency procedures still needs improvement, according to the report// released by Wait Time Alliance of the Canadian Medical Association. The report also stresses the importance of timely information to patients about exact treatment times, especially for priority procedures.

Most hospitals have managed to keep up the target, which is good news. Nearly 80% of the patients who required bypass surgery received the treatment on time. But patients for ‘knee replacement surgeries’ had to face the brunt of long waiting times. Further, reporting practices were different across provinces, making it difficult for patients to make a relative study of the progress.

Five priority areas were classified by health ministers, - cardiac care, cancer care, sight restoration, joint replacement and diagnostic imaging. Now, benchmarks have been given for all these categories. The Alliance also addressed the impediments for improvement in the priority areas. Grades were accorded for each area, such as - A for cardiac care and sight restoration, a B for CT scans, hip replacement and cancer care, and C for knee replacement and MRIs. Steps should be taken to reduce waiting times even in the areas that have not been listed by the Alliance.
'"/>




Page: 1

Related medicine news :

1. Apollo Hospitals to consider listing on US Bourses in 2003
2. Apollo Hospitals Collaborates With Histostem For Stem Cell Therapy
3. Indian Hospitals – A Destination For Quality Medical Care
4. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
5. Quality Awareness In Hospitals Can Reduce Mortality Rate Of Patients
6. First PET-CT guided radiotherapy in India was performed by Apollo Hospitals
7. Delhi Government To Interlink All Major Hospitals Through e-Governance
8. Global Hospitals coming to city of Joy
9. Indias Hospitals Among The Best, Says Renuka Chowdhury
10. Apollo Hospitals Short-listed to Provide Diagnostics in the UK
11. Apollo Hospitals to invest Rs 350 cr to add 1,800 beds
Post Your Comments:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...e of the major cause of obesity- overeating, which...hat it could be addictive.// Researchers used an ...tomach to the brain to understand the exact road t...kes and the tough ride ahead for those in its grip...
...hers in the United States has discovered what may ...lon cancer.// The scientists from the University...h in mice by halting the activity of a single enzy.... Blocking this enzyme shuts down the toxic netwo...
...ges facing researchers today, and recent research ...ntain a growing epidemic.// The World Health Organ...ple in the world tackling overweight problems, of ...ientists have narrowed their sights on a new molec...
... won this year's Nobel Prize for Medicine in recog...ouble-stranded RNA, it was announced here Monday. ...RNA interference in awarding them the 10-million-k...e. The award winners have discovered "a fundament...
Other Medicine News:Health News:Brain behind the Brawn: Vital Molecule in the Brain Controls Appetite 2Health News:Two Americans Share 2006 Nobel Medicine Prize 2
(Date:10/10/2008)...10 /- Boston Scientific,Cor...e of the Company,s major,events and press announce...(CRF) twentieth annual Transcatheter Cardiovascula...uns from October 12 to 17 in Washington, D.C., Bo... safety and,efficacy data on its TAXUS(R) Express2...
(Date:10/9/2008)...ncreased Sales and Marketing Efforts to Accelerate...ystem, MENLO PARK, Calif., Oct. 9 /-...vices for the percutaneous repair of cardiac valve...team with the appointment of,Sean Cleary as senior...nd,Chris Richardson, as vice president of sales., ...
(Date:10/8/2008).... 8 /PRNewswire-USNewswire/ -- The facts are,overw...IV/AIDS in,sub-Saharan Africa. More than 35,000,00...ave already died of AIDS. The Foundation for Hospi... dying and their families,find compassion and reli...vative partnering initiative links African hospice...
(Date:10/8/2008)...ram to be Discontinued and Headcount to be Reduced...tfolio Review; Zanolimumab Program to be Disconti... Employees, COPENHAGEN,...MX: GEN),announced today that it is discontinuing ...tion, as a result of a portfolio review and,assess...
Breaking Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay 196 1Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay 196 2Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay 196 3Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay 196 4PRA International Adds Dr Susan Stansfield as Executive Vice President 529 1PRA International Adds Dr Susan Stansfield as Executive Vice President 529 2PRA International Adds Dr Susan Stansfield as Executive Vice President 529 3AKELA Pharma Inc announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN 28R 29 trial 526 1AKELA Pharma Inc announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN 28R 29 trial 526 2AKELA Pharma Inc announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN 28R 29 trial 526 3Vical to Present at Upcoming Investor Conferences 367 1Vical to Present at Upcoming Investor Conferences 367 2
...7, 2007 - BioLineRx Ltd.,(TASE:BLRX), Israel,s lea...clinical data from trials of BL-1040 demonstrating...tion of the myocardium,after a myocardial infarcti...n and eventual heart failure in a pig model. Profe...rdiac Research,Institute at Sheba Medical Center i...
...rial data underlines M6G,s,benefit compared to mor...MBRIDGE, England, 7th March 2007 - CeNeS Pharmaceu...maceutical company today,announces additional data...(morphine-6-glucuronide) in over 500 patients with...d on 20th February,showed that M6G provided equiva...
Other Medicine Technology:BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 2CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 3CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 4CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 5CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 6CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 7
Cold light source triple outlet.
Cold light source dual outlet.
Cold light source dual outlet.
The 4150S is a state of the art 150 Watt halogen light source with an integrated intensity control and a standard coupler to connect optical fiber light guides. This light source distinguishes itself
Medicine Products: